Leadership Overview
Roivant has 5 executives leading key functions including strategy, information technology, operations, medical affairs, and general management.
Driven by a commitment to patient well-being, Roivant focuses on accelerating the development of promising drug candidates and delivering innovative healthcare technologies, aiming to transform patient care through scientific advancement and operational excellence.
Driven by a commitment to patient well-being, Roivant focuses on accelerating the development of promising drug candidates and delivering innovative healthcare technologies, aiming to transform patient care through scientific advancement and operational excellence.
Leadership Roles at Roivant
Matthew Gline - Chief Executive Officer
Matthew Gline, the Chief Executive Officer at Roivant, directs the company's overarching strategy and operational execution. Gline guides Roivant's mission to advance late-stage drug candidates and integrate innovative healthcare technologies, ensuring alignment with patient needs and market opportunities. Overseeing all business units, the Chief Executive Officer drives the company's growth trajectory and financial performance. This leadership position involves fostering a culture of innovation and accountability across the organization. By championing strategic partnerships and resource allocation, Matthew Gline ensures the efficient progression of Roivant's diverse pipeline, solidifying the company's position as a leader in tech-enabled healthcare solutions.

Stephanie Griffin - Chief Operating Officer (Roivant Platforms)
Stephanie Griffin, the Chief Operating Officer (Roivant Platforms) at Roivant, spearheads the operational execution of Roivant's platform companies. Griffin ensures efficient resource deployment and strategic alignment across the portfolio, driving the completion of late-stage drug development programs. Overseeing platform operations, the Chief Operating Officer (Roivant Platforms) optimizes processes for maximum impact and speed. This leadership function involves managing cross-functional teams and fostering collaboration to overcome development hurdles. By streamlining operational workflows, Stephanie Griffin accelerates the delivery of innovative healthcare technologies to patients, reinforcing Roivant's commitment to transforming healthcare.

Eric Venker - President
Eric Venker, the President at Roivant, drives strategic initiatives and operational excellence across the organization. Venker focuses on enhancing the company's capabilities in completing late-stage drug development and delivering novel healthcare technologies. Overseeing key strategic projects, the President ensures efficient execution and resource allocation to maximize impact. This leadership position involves fostering strong relationships with stakeholders and advancing Roivant's overall business objectives. By championing innovation and operational rigor, Eric Venker plays a vital role in Roivant's mission to bring transformative healthcare solutions to patients worldwide.

Ian Rosenblum - Chief Information Officer
Ian Rosenblum, the Chief Information Officer at Roivant, architects the company's technology infrastructure and digital strategy. Rosenblum ensures robust data management, cybersecurity, and scalable IT systems to support Roivant's drug development and healthcare technology initiatives. Overseeing all technology operations, the Chief Information Officer drives digital transformation and enhances operational efficiency. This role involves implementing advanced analytics and AI solutions to accelerate research and development processes. By managing the company's technological resources, Ian Rosenblum enables seamless data integration and secure information flow across all departments, directly supporting Roivant's mission to deliver innovative healthcare solutions.

Deya Corzo - Chief Medical Officer, -Residence
Deya Corzo, the Chief Medical Officer, -Residence at Roivant, provides critical medical and scientific leadership for drug development programs. Corzo guides clinical strategy and ensures the scientific integrity of late-stage candidates, aligning medical insights with patient needs. Overseeing clinical research, the Chief Medical Officer, -Residence drives the evaluation of therapeutic potential and safety profiles. This role involves close collaboration with R&D teams and external medical experts to advance promising treatments. By applying deep medical expertise, Deya Corzo contributes significantly to Roivant's mission of delivering innovative healthcare technologies and improving patient outcomes.
Explore Leadership Teams in Business Services
Founded in 1828, Bureau Veritas is an international certification agency. The company operates through the following businesses: Marine and Offshore, Industry, In-Service Inspection and Verification, Construction, Certification, Commodities, Consumer Products, and Government Services and International Trade. Bureau Veritas is based in France.
Company Leadership MB

AK
For nearly four decades, FTI has proudly served the United States Department of Defense, Intelligence Community and the Federal Government with mission-tailored, technology-enabled solutions to help them make the best decisions possible for their missions.Headquartered in Dayton, Ohio, FTI has seven additional facilities with varying levels of clearance, along with a presence in 39 states and Puerto Rico.
Company Leadership JL
GM
BM
Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making.
Company Leadership BK
HG
JS
DR
Ascential Technologies delivers design, development and manufacturing solutions that tackle the toughest problems, unlocking performance for mission-critical companies. With global scale, deep expertise and practical know-how born from seven decades on the cutting edge of automation, Ascential partners with customers every step of the way to accelerate and realize their innovations. We deliver a range of offerings, from the most complex diagnostic tools used in life sciences, to the development and testing of adaptive safety systems in electric vehicles, to the inspection of advanced microprocessors for functional integrity and much more. Through our diverse portfolio of solutions, Ascential helps customers accelerate their innovation, mitigate risk, drive competitive differentiation, and reduce time to market at scale.
Company Leadership
GD
DB
SO